Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody
- 1 January 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in Protein Engineering, Design and Selection
- Vol. 9 (3) , 299-305
- https://doi.org/10.1093/protein/9.3.299
Abstract
Antibody fragments produced by bacterial fermentation lack natural effector functions, Bispecific antibody fragments, however, can be endowed with effector functions, for example cell-mediated killing, by binding to and retargeting of cytotoxic cells, Diabodies are a class of engineered antibody fragments with two antigen binding sites, consisting of two associated chains; each chain consists of heavy and light chain variable domains linked by a short polypeptide linker, In contrast to IgG, or other antibody fragments in which the two binding sites can take up a range of orientations and spacings, the diabody structure is more rigid and compact, with the two binding sites separated by 65 Angstrom (less than half the distance in IgG), To establish whether diabodies could also be used in cell-mediated killing, we have explored the use of a bispecific diabody binding to an idiotypic marker on mouse B-cell lymphoma (BCL-1) and to mouse CD3, The bispecific diabody activated naive T-cells and also mediated the specific killing of the lymphoma cells by cytotoxic T-cells, The diabody was less active in T-cell activation but 10-fold more active (w/v) in killing than an analogous bispecific IgG.Keywords
This publication has 12 references indexed in Scilit:
- Triggering T cells by otherwise inert hybrid anti-CD3/antitumor antibodies requires encounter with the specific target cell.The Journal of Experimental Medicine, 1989
- Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.Proceedings of the National Academy of Sciences, 1989
- Idiotypic vaccination as a treatment for a B cell lymphoma.The Journal of Immunology, 1988
- Escherichia coli Secretion of an Active Chimeric Antibody FragmentScience, 1988
- Assembly of a Functional Immunoglobulin F v Fragment in Escherichia coliScience, 1988
- Identification of a monoclonal antibody specific for a murine T3 polypeptide.Proceedings of the National Academy of Sciences, 1987
- Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.Proceedings of the National Academy of Sciences, 1986
- Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes.Proceedings of the National Academy of Sciences, 1985
- Preparation of Bispecific Antibodies by Chemical Recombination of Monoclonal Immunoglobulin G 1 FragmentsScience, 1985
- Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies.The Journal of Experimental Medicine, 1984